Results 211 to 220 of about 80,194 (337)

Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts

Pediatric Blood &Cancer, Volume 73, Issue 1, January 2026.
ABSTRACT Background Hemophilia A (HA) is a rare bleeding disorder caused by coagulation factor VIII (FVIII) deficiency. Prophylactic FVIII replacement therapy is essential for preventing bleeds, but it carries a risk of inhibitor development, especially in previously untreated and minimally treated patients (PUPs and MTPs, respectively).
Sarina Levy‐Mendelovich, Tlalit Barhod, Ivan Budnik, Jonathan Lancashire, Jesal Patel, Assaf Arie Barg, Einat Avishai, Rima Dardik, Tami Brutman Barazani, Tami Livnat, Jayashree Motwani, Gili Kenet   +11 more
wiley   +1 more source

Balancing Bleeding and Clot: Type 2 Heparin-Induced Thrombocytopenia With Extensive Thromboses in a Patient With Subdural Hematoma. [PDF]

Cureus
Annan GK, Enninful E, Egwuonwu C, Atencah SE, Berchie PO.   +4 more
europepmc   +1 more source

[Intracranial venous thrombosis].

Gaceta medica de Mexico, 1978
J H, Mateos-Gómez, J M, Alemán-Pedroza, B, Estañol-Vidal, M, Loyo-Varela   +3 more
openaire   +1 more source

Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 1, January 2026.
ABSTRACT Asundexian is a potent, selective, and reversible inhibitor of activated clotting Factor XI currently under development for secondary prevention of recurrent ischemic stroke in the ongoing Phase III OCEANIC‐STROKE study (NCT05686070). Here, we report the development of a population pharmacokinetic (popPK) model for asundexian.
Ashraf Yassen, Friederike Kanefendt, Jochen Zisowsky, Astrid Broeker, Hardi Mundl, Peter Vis, Dirk Garmann, Jan Berkhout   +7 more
wiley   +1 more source

Association Between Pulse Wave Velocity and Cerebral Small Vessel Disease: A Scoping Review. [PDF]

Cureus
Kahook Z, Nedjar O, Escudero A, Montgomery C, Ropelewski J, Mayrovitz HN.   +5 more
europepmc   +1 more source

Percutaneous Reperfusion Therapies vs. Anticoagulation in Patients With Acute Intermediate‐High‐Risk Pulmonary Embolism: The PRETHA Randomized Clinical Trial

Pulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT The optimal treatment strategy for patients with acute intermediate–high‐risk pulmonary embolism (PE) remains uncertain. This randomized clinical trial (PRETHA) aimed to evaluate the efficacy and safety of percutaneous reperfusion therapies—trans‐catheter thrombectomy and trans‐catheter thrombolysis—compared with standard anticoagulation ...
Taida Ivanauskienė, Andrius Berūkštis, Greta Burneikaitė, Aurelija Daubaraitė, Kastė Ivanauskaitė, Mindaugas Matačiūnas, Giedrius Navickas, Rasa Kūgienė, Marcin Kurzyna, Sigita Glaveckaitė   +9 more
wiley   +1 more source

Spontaneous thrombosis in giant intracranial aneurysms. [PDF]

Quant Imaging Med Surg
Wang J, Liu Y.
europepmc   +1 more source

Spontaneous intracranial hypotension complicated with cerebral venous thrombosis and subdural effusion: a case report

, 2016
Murali Krishna Menon, Thara Prathap, Muhammed Jasim Abdul Jalal   +2 more
openalex   +1 more source

Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes

British Journal of Haematology, Volume 208, Issue 1, Page 274-284, January 2026.
Summary Patients with immune thrombocytopenia (ITP) remain a challenge to diagnose, manage and predict bleeding risk. A comprehensive assessment of platelet function may aid clinical management. This study assessed platelet parameters to predict bleeding in ITP.
Sidra A. Ali, Sarah M. Hicks, Lucy A. Coupland, Simone A. Brysland, Vijay Bhoopalan, Yee Lin Thong, Amandeep Kaur, Robert K. Andrews, Elizabeth E. Gardiner, Philip Y.‐I. Choi   +9 more
wiley   +1 more source

Extracorporeal Cardiopulmonary Resuscitation for 78-min Cardiac Arrest due to Suspected Cerebral Venous Sinus Thrombosis. [PDF]

Case Rep Crit Care
Wu D, Qin H.
europepmc   +1 more source